Pointe Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
6,784
+55
| +0.8% | +$3.84K | 0.25% | 93 |
|
|
2025
Q1 | $495K | Hold |
6,729
| – | – | 0.29% | 90 |
|
|
2024
Q4 | $441K | Buy |
6,729
+1,275
| +23% | +$83.5K | 0.25% | 98 |
|
|
2024
Q3 | $425K | Hold |
5,454
| – | – | 0.25% | 101 |
|
|
2024
Q2 | $425K | Hold |
5,454
| – | – | 0.26% | 95 |
|
|
2024
Q1 | $370K | Hold |
5,454
| – | – | 0.23% | 109 |
|
|
2023
Q4 | $367K | Buy |
5,454
+69
| +1% | +$4.65K | 0.26% | 99 |
|
|
2023
Q3 | $365K | Buy |
5,385
+33
| +0.6% | +$2.24K | 0.27% | 94 |
|
|
2023
Q2 | $383K | Buy |
5,352
+88
| +2% | +$6.3K | 0.29% | 97 |
|
|
2023
Q1 | $365K | Sell |
5,264
-25
| -0.5% | -$1.74K | 0.26% | 94 |
|
|
2022
Q4 | $359K | Hold |
5,289
| – | – | 0.28% | 91 |
|
|
2022
Q3 | $290K | Buy |
5,289
+81
| +2% | +$4.44K | 0.23% | 110 |
|
|
2022
Q2 | $344K | Hold |
5,208
| – | – | 0.26% | 102 |
|
|
2022
Q1 | $345K | Buy |
5,208
+150
| +3% | +$9.94K | 0.22% | 115 |
|
|
2021
Q4 | $295K | Buy |
+5,058
| New | +$295K | 0.18% | 120 |
|